|
CA2974651A1
(en)
|
2014-01-24 |
2015-07-30 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Smc combination therapy for the treatment of cancer
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
MX386886B
(es)
|
2014-09-09 |
2025-03-12 |
Janssen Biotech Inc |
Combinación de anticuerpos anti-cd38 y ácido todo-trans retinoico para usarse en terapias.
|
|
US10793630B2
(en)
|
2014-12-04 |
2020-10-06 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute myeloid leukemia
|
|
KR102602754B1
(ko)
|
2015-05-20 |
2023-11-14 |
얀센 바이오테크 인코포레이티드 |
경쇄 아밀로이드증 및 다른 cd38-양성 혈액학적 악성종양을 치료하기 위한 항-cd38 항체
|
|
PE20181323A1
(es)
|
2015-06-22 |
2018-08-14 |
Janssen Biotech Inc |
Terapias de combinacion para enfermedades malignas hematologicas con anticuerpos anti-cd38 e inhibidores de survivina
|
|
PT3313441T
(pt)
*
|
2015-06-24 |
2024-05-07 |
Janssen Biotech Inc |
Modulação imunitária e tratamento de tumores sólidos com anticorpos que se ligam especificamente a cd38
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
RU2711380C2
(ru)
*
|
2015-07-16 |
2020-01-16 |
Байоксэл Терапьютикс, Инк. |
Новый подход к лечению рака с применением иммуномодуляции
|
|
BR112018008901A8
(pt)
|
2015-11-03 |
2019-02-26 |
Janssen Biotech Inc |
formulações subcutâneas de anticorpos anti-cd 38 e seus usos
|
|
US10781261B2
(en)
|
2015-11-03 |
2020-09-22 |
Janssen Biotech, Inc. |
Subcutaneous formulations of anti-CD38 antibodies and their uses
|
|
EP3442584B1
(en)
|
2016-03-15 |
2021-07-28 |
Seagen Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
US11110179B2
(en)
|
2016-06-03 |
2021-09-07 |
Seagen Inc. |
Combination of CD33 antibody drug conjugates with chemotherapeutic agents
|
|
US11191771B2
(en)
|
2016-06-09 |
2021-12-07 |
Seagen Inc. |
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors
|
|
WO2019089832A1
(en)
|
2017-10-31 |
2019-05-09 |
Janssen Biotech, Inc. |
Methods of treating high risk multiple myeloma
|
|
WO2021138407A2
(en)
|
2020-01-03 |
2021-07-08 |
Marengo Therapeutics, Inc. |
Multifunctional molecules that bind to cd33 and uses thereof
|
|
US12213801B2
(en)
|
2020-10-02 |
2025-02-04 |
Cilag Gmbh International |
Surgical visualization and particle trend analysis system
|
|
US12484897B2
(en)
|
2020-10-02 |
2025-12-02 |
Cilag Gmbh International |
Surgical instrument with adaptive configuration control
|
|
US11748924B2
(en)
|
2020-10-02 |
2023-09-05 |
Cilag Gmbh International |
Tiered system display control based on capacity and user operation
|
|
US11992372B2
(en)
|
2020-10-02 |
2024-05-28 |
Cilag Gmbh International |
Cooperative surgical displays
|
|
US12472032B2
(en)
|
2020-10-02 |
2025-11-18 |
Cilag Gmbh International |
Monitoring of user visual gaze to control which display system displays the primary information
|
|
US11963683B2
(en)
|
2020-10-02 |
2024-04-23 |
Cilag Gmbh International |
Method for operating tiered operation modes in a surgical system
|
|
US11672534B2
(en)
|
2020-10-02 |
2023-06-13 |
Cilag Gmbh International |
Communication capability of a smart stapler
|
|
US11877897B2
(en)
|
2020-10-02 |
2024-01-23 |
Cilag Gmbh International |
Situational awareness of instruments location and individualization of users to control displays
|
|
US12016566B2
(en)
|
2020-10-02 |
2024-06-25 |
Cilag Gmbh International |
Surgical instrument with adaptive function controls
|
|
US12064293B2
(en)
|
2020-10-02 |
2024-08-20 |
Cilag Gmbh International |
Field programmable surgical visualization system
|
|
US11830602B2
(en)
|
2020-10-02 |
2023-11-28 |
Cilag Gmbh International |
Surgical hub having variable interconnectivity capabilities
|
|
CN116948029A
(zh)
|
2022-04-20 |
2023-10-27 |
南京融捷康生物科技有限公司 |
一种包含IgG类Fc区变体的抗体及其用途
|